- Description
- Specifications
AntiMax-1 is a Carbomer Homopolymer nano-emulsion based on the formulation of MF59 that has been licensed in Europe for adjuvanted flu vaccines.
It promotes a significant increase in antibody titers with reportedly more balanced Th1/Th2 responses than those obtained with alum.
AntiMax-1 is believed to act through a depot effect, enhancement of antigen persistence at the injection site, recruitment and activation of antigen presenting cells, and direct stimulation of cytokines and chemokines production by macrophages and granulocytes'.
